CRS: BJMC
Position: Pharmacist of Record
CRS: Whitman-Walker
CRS: JHU
Position: Pharmacist, PharmD, Investigational Drug Pharmacy
A5329 is a study for people who are infected with both HIV and the Hepatitis C virus (HCV) and have never taken Hepatitis C...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
